ANTON GUETH Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANTON GUETH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANTON GUETH. ANTON GUETH is Director in ANTARES PHARMA, INC. ($ATRS) and Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB).
Latest Insider Trading Transactions of ANTON GUETH
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.66 | 40,000 | 66,400 | 0 | |
| May 06 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.66 | 40,000 | 66,400 | 542,125 | 502.1 K to 542.1 K (+7.97 %) |
| May 06 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.66 | 40,000 | 66,400 | 0 | |
| May 06 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.66 | 40,000 | 66,400 | 542,125 | 502.1 K to 542.1 K (+7.97 %) |
| May 03 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.66 | 72,669 | 120,631 | 0 | |
| May 03 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.66 | 72,669 | 120,631 | 502,125 | 429.5 K to 502.1 K (+16.92 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 2.73 | 58,246 | 159,012 | 58,246 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Grant | A | 2.73 | 30,220 | 82,501 | 429,456 | 399.2 K to 429.5 K (+7.57 %) |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 2.92 | 46,729 | 136,449 | 46,729 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Grant | A | 2.92 | 23,973 | 70,001 | 326,749 | 302.8 K to 326.7 K (+7.92 %) |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 2.66 | 80,318 | 213,646 | 80,318 | |
| Jun 06 2016 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.12 | 150,000 | 168,000 | 150,000 | |
| Mar 21 2016 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | P | 0.72 | 50,000 | 36,000 | 302,776 | 252.8 K to 302.8 K (+19.78 %) |
| Jan 08 2016 | NAVB | NAVIDEA BIOPHARMAC ... | GUETH ANTON | Director | Grant | A | 1.22 | 16,918 | 20,640 | 38,918 | 22 K to 38.9 K (+76.90 %) |
| Jul 06 2015 | NAVB | NAVIDEA BIOPHARMAC ... | GUETH ANTON | Director | Grant | A | 0.00 | 22,000 | 22 | 22,000 | 0 to 22 K |
| Jun 01 2015 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 2.18 | 99,395 | 216,681 | 99,395 | |
| May 05 2006 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.55 | 10,000 | 15,500 | 10,000 | |
| Jan 05 2006 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.54 | 20,000 | 30,800 | 62,583 | |
| Jan 04 2005 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 34,021 | |
| Oct 25 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.40 | 1,250 | 1,750 | 14,583 | |
| Jul 23 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 0.70 | 1,250 | 875 | 0 | |
| Jun 23 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 0.90 | 2,000 | 1,800 | 0 | |
| May 25 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 0.95 | 500 | 475 | 0 | |
| May 12 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.01 | 2,000 | 2,020 | 0 | |
| Apr 20 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.32 | 500 | 660 | 0 | |
| Apr 20 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.32 | 500 | 660 | 0 | |
| Apr 07 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.40 | 2,000 | 2,800 | 35,083 | |
| Mar 10 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.25 | 8,333 | 10,416 | 33,083 | |
| Mar 10 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Grant | A | 1.00 | 25,000 | 25,000 | 40,000 | 15 K to 40 K (+166.67 %) |
| Feb 17 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.08 | 2,000 | 2,160 | 24,750 |
Page: 1